643
Views
7
CrossRef citations to date
0
Altmetric
Review

Computational representations of protein–ligand interfaces for structure-based virtual screening

, , , ORCID Icon &
Pages 1175-1192 | Received 05 Nov 2020, Accepted 11 May 2021, Published online: 03 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sarah Naomi Bolz & Michael Schroeder. (2023) Promiscuity in drug discovery on the verge of the structural revolution: recent advances and future chances. Expert Opinion on Drug Discovery 18:9, pages 973-985.
Read now

Articles from other publishers (5)

Xiaoting Li, Dongmei Zhao, Xinrong Zhao, Ping Cheng, Fulei Li, Jichao Sun, Yubao Li, Jingwen Bai & Xiuying Zhang. (2023) The activity and mechanism of vidofludimus as a potent enzyme inhibitor against NDM-1-positive E. coli. European Journal of Medicinal Chemistry 250, pages 115225.
Crossref
Janani Durairaj, Dick de Ridder & Aalt D.J. van Dijk. (2023) Beyond sequence: Structure-based machine learning. Computational and Structural Biotechnology Journal 21, pages 630-643.
Crossref
Ge Wang, Yuhao Bai, Jiarui Cui, Zirui Zong, Yuan Gao & Zhen Zheng. (2022) Computer-Aided Drug Design Boosts RAS Inhibitor Discovery. Molecules 27:17, pages 5710.
Crossref
Yeji Wang, Shuo Wu, Yanwen Duan & Yong Huang. (2022) A point cloud-based deep learning strategy for protein–ligand binding affinity prediction. Briefings in Bioinformatics 23:1.
Crossref
Feiqi Wang, Yun-Ti Chen, Jinn-Moon Yang & Tatsuya Akutsu. (2022) A novel graph convolutional neural network for predicting interaction sites on protein kinase inhibitors in phosphorylation. Scientific Reports 12:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.